Holding(s) in Company

RNS Number : 8887E
Diaceutics PLC
10 November 2020
 

TR-1: S tandard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i


1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii :

Diaceutics Plc

 

1b. Please indicate if the issuer is a non-UK issuer   (please mark with an "X" if appropriate)

Non-UK issuer


2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments


An event changing the breakdown of voting rights


Other (please specify)iii:


3. Details of person subject to the notification obligation iv

Name

Danske Bank A/S

City and country of registered office (if applicable)

DK - 1092 Copenhagen

4. Full name of shareholder(s) (if different from 3.) v

Name

 

DANSKE INVEST MANAGEMENT COMPANY (SOCIÉTE ANONYME)/DANSKE INVEST FCP LUXEMBOURG

 

DANSKE INVEST FUND MANAGEMENT LTD./DANSKE INVEST FINLAND

 

PROXY VOTES SUPPLIED BY INVESTERINGSFORENINGEN DANSKE INVEST

 

City and country of registered office (if applicable)


5. Date on which the threshold was crossed or reached vi :

09-11-2020

6. Date on which issuer notified (DD/MM/YYYY):

10-11-2020

7. Total positions of person(s) subject to the notification obligation 4.77109


% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments
(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuer vii

Resulting situation on the date on which threshold was crossed or reached

3.10

 


  3.10

 

   

   84,068,923.00

 

Position of previous notification (if

applicable)

 

  N/A

 


N/A


 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viii

A: Voting rights attached to shares

Class/type of
shares

ISIN code (if possible)

Number of voting rights ix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB00BJQTGV64

 


 

 

   2,605,164.00

 

 


3.10











SUBTOTAL 8. A

 

   2,605,164.00

 

3.10

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expiration
date
x

Exercise/
Conversion Period
xi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights


















SUBTOTAL 8. B 1



 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expiration
date
x

Exercise/
Conversion Period
xi

Physical or cash

settlement xii

Number of voting rights

% of voting rights






















SUBTOTAL 8.B.2



 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii


Full chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held starting with the ultimate controlling natural person or legal entity
xiv (please add additional rows as necessary)

X

Name xv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Danske Invest FCP Luxembourg

13, rue Edward Steichen

L-2540 Luxembourg

- A mutual fund under management of

Danske Invest Management Company (Société Anonyme)

13, rue Edward Steichen

L-2540 Luxembourg

- a subsidiary 100% owned by

Danske Bank International S.A,

13, rue Edward Steichen

L-2540 Luxembourg

- a subsidiary 100% owned by Danske Bank A/S

 




Danske Invest Finland

Hiililaiturinkuja 2, P.O. Box 1553,

FIN-00180 Helsinki

Finland

- a mutual fund under management of

Danske Invest Fund Management Ltd.

Hiililaiturinkuja 2, P.O. Box 1553,

FIN-00180 Helsinki

Finland

- a subsidiary 100% owned by

Danske Bank plc

Hiililaiturinkuja 2, P.O. Box 1568

00075 Danske Bank, Finland

- a subsidiary 100% owned by Danske Bank A/S




Proxy shares given to Danske Capital, a division of Danske Bank A/S (so no separate legal identity) by:

 

lnvesteringsforeningen Danske Invest

Parallelvej 17

DK-2800 Kgs. Lyngby

Denmark













10. In case of proxy voting, please identify:

Name of the proxy holder

DANSKE Capital, a division of Danske Bank A/S

The number and % of voting rights held

Danske Invest Europa Small cap

(1,076,798.00 shs/votings rights = 1.28%)

 

Danske Invest Europa Small cap AKK

(94,988.00 shs/votings rights = 0.11%)

The date until which the voting rights will be held

No set expiry date


11. Additional information xvi


 

Place of completion

DK - 1092 Copenhagen K

Date of completion

10-11-2020

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLQBLFFBFLXFBB

Companies

Diaceutics (DXRX)
UK 100

Latest directors dealings